Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: Evaluative methodology for DAB chromogenic immunostaining

Brain Tumor Pathology

Volumn 31, Issue 2, 2014, Pages 85-93

  Hirano, Hirofumi ^a   Yonezawa, Hajime ^a   Yunoue, Shunji ^a   Habu, Mika ^a   Uchida, Hiroyuki ^a   Yoshioka, Takako ^a   Kishida, Shosei ^a   Kishida, Michiko ^a   Oyoshi, Tatsuki ^a   Fujio, Shingo ^a   Sugata, Sei ^a   Yamahata, Hitoshi ^a   Hanaya, Ryousuke ^a   Arita, Kazunori ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Color deconvolution; Fzd2; Fzd6; Glioblastoma; Wnt5a

Indexed keywords

FZD2 PROTEIN; FZD6 PROTEIN; ONCOPROTEIN; RYK PROTEIN; UNCLASSIFIED DRUG; WNT5A PROTEIN; FRIZZLED PROTEIN; FZD2 PROTEIN, HUMAN; FZD6 PROTEIN, HUMAN; PROTEIN TYROSINE KINASE; RYK PROTEIN, HUMAN; WNT PROTEIN; WNT5A PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DENSITY; CLINICAL ARTICLE; CLINICAL EVALUATION; DOWN REGULATION; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL RATE; SURVIVAL TIME; UPREGULATION; AGED; BRAIN TUMOR; COMPARATIVE STUDY; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; BRAIN NEOPLASMS; FEMALE; FRIZZLED RECEPTORS; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SURVIVAL RATE; WNT PROTEINS;

EID: 84899924230     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-013-0153-1     Document Type: Article

References (41)

1. Yang Y, Topol L, Lee H, Wu J (2003) Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130:1003-1015 (Pubitemid 36372019)
2. Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY, Kim KW (2007) Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett 257:172-181 (Pubitemid 47538822)
3. Huang Y, Liu G, Zhang B, Xu G, Xiong W, Yang H (2010) Wnt-5a regulates proliferation in lung cancer cells. Oncol Rep 23:177-181
4. Peng L, Ren LB, Dong G, Wang CL, Xu P, Ye L, Zhou XD (2010) Wnt5a promotes differentiation of human dental papilla cells. Int Endod J 43:404-412
5. Kamino M, Kishida M, Kibe T, Ikoma K, Iijima M, Hirano H, Tokudome M, Chen L, Koriyama C, Yamada K, Arita K, Kishida S (2011) Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci 102:540-548
6. Laeremans H, Rensen SS, Ottenheijm HC, Smits JF, Blankesteijn WM (2010) Wnt/frizzled signalling modulates the migration and differentiation of immortalized cardiac fibroblasts. Cardiovasc Res 87:514-523
7. Wouda RR, Bansraj MR, de Jong AW, Noordermeer JN, Fradkin LG (2008) Src family kinases are required for WNT5 signaling through the Derailed/RYK receptor in the Drosophila embryonic central nervous system. Development 135:2277-2287
8. Miyashita T, Koda M, Kitajo K, Yamazaki M, Takahashi K, Kikuchi A, Yamashita T (2009) Wnt-Ryk signaling mediates axon growth inhibition and limits functional recovery after spinal cord injury. J Neurotrauma 26:955-964
9. Ruifrok AC, Johnston DA (2001) Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23:291-299 (Pubitemid 32762920)
10. Preusser M, Charles Janzer R, Felsberg J, Reifenberger G, Hamou MF, Diserens AC, Stupp R, Gorlia T, Marosi C, Heinzl H, Hainfellner JA, Hegi M (2008) Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. Brain Pathol 18:520-532
11. Elmlinger MW, Deininger MH, Schuett BS, Meyermann R, Duffner F, Grote EH, Ranke MB (2001) In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. Endocrinology 142:1652-1658 (Pubitemid 32299696)
12. Hirano H, Lopes MB, Laws ER Jr, Asakura T, Goto M, Carpenter JE, Karns LR, VandenBerg SR (1999) Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neurooncology 1:109-119
13. Viana-Pereira M, Lopes JM, Little S, Milanezi F, Basto D, Pardal F, Jones C, Reis RM (2008) Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas. Anticancer Res 28:913-920 (Pubitemid 351578937)
14. Burel-Vandenbos F, Benchetrit M, Miquel C, Fontaine D, Auvergne R, Lebrun-Frenay C, Cardot-Leccia N, Michiels JF, Paquis-Flucklinger V, Virolle T (2011) EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis. J Neurooncol 102:171-178
15. Newcomb EW, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL, Miller DC (1998) Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol 8:655-667 (Pubitemid 28460924)
16. Helps SC, Thornton E, Kleinig TJ, Manavis J, Vink R (2012) Automatic nonsubjective estimation of antigen content visualized by immunohistochemistry using color deconvolution. Appl Immunohistochem Mol Morphol 20:82-90
17. Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D (2005) Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. J Natl Cancer Inst 97:880-887 (Pubitemid 41417939)
18. Tilley WD, Lim-Tio SS, Horsfall DJ, Aspinall JO, Marshall VR, Skinner JM (1994) Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res 54:4096-4102 (Pubitemid 24258115)
19. Matkowskyj KA, Schonfeld D, Benya RV (2000) Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab. J Histochem Cytochem 48:303-312
20. Kaczmarek E, Gorna A, Majewski P (2004) Techniques of image analysis for quantitative immunohistochemistry. Rocz Akad Med Bialymst 49(Suppl 1):155-158
21. Vrekoussis T, Chaniotis V, Navrozoglou I, Dousias V, Pavlakis K, Stathopoulos EN, Zoras O (2009) Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model. Anticancer Res 29:4995-4998
22. Pham NA, Morrison A, Schwock J, Aviel-Ronen S, Iakovlev V, Tsao MS, Ho J, Hedley DW (2007) Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn Pathol 2:8
23. Matkowskyj KA, Cox R, Jensen RT, Benya RV (2003) Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number. J Histochem Cytochem 51:205-214 (Pubitemid 36160047)
24. Cornish TC, Halushka MK (2009) Color deconvolution for the analysis of tissue microarrays. Anal Quant Cytol Histol 31:304-312
25. Safadi RA, Musleh AS, Al-Khateeb TH, Hamasha AA (2010) Analysis of immunohistochemical expression of k19 in oral epithelial dysplasia and oral squamous cell carcinoma using color deconvolution-image analysis method. Head Neck Pathol 4:282-289
26. Mino-Kenudson M, Chirieac LR, Law K, Hornick JL, Lindeman N, Mark EJ, Cohen DW, Johnson BE, Janne PA, Iafrate AJ, Rodig SJ (2010) A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin Cancer Res 16:1561-1571
27. Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J, Skubitz AP, Metzger GJ, Schmechel SC (2012) Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol 7:42
28. Yamaguchi TP, Bradley A, McMahon AP, Jones S (1999) A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126:1211-1223 (Pubitemid 29182117)
29. Liu W, Li L, Li G, Garritano F, Shanske A, Frenz DA (2008) Coordinated molecular control of otic capsule differentiation: functional role of Wnt5a signaling and opposition by sfrp3 activity. Growth Factors 26:343-354 (Pubitemid 352781847)
30. Nishizuka M, Koyanagi A, Osada S, Imagawa M (2008) Wnt4 and Wnt5a promote adipocyte differentiation. FEBS Lett 582:3201-3205
31. Paina S, Garzotto D, DeMarchis S, Marino M, Moiana A, Conti L, Cattaneo E, Perera M, Corte G, Calautti E, Merlo GR (2011) Wnt5a is a transcriptional target of Dlx homeogenes and promotes differentiation of interneuron progenitors in vitro and in vivo. J Neurosci 31:2675-2687
32. Valencia J, Hernandez-Lopez C, Martinez VG, Hidalgo L, Zapata AG, Vicente A, Varas A, Sacedon R (2011) Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features. J Immunol 187:4129-4139
33. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1:279-288 (Pubitemid 41039152)
34. Katoh M (2009) Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades. Int J Mol Med 23:763-769
35. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W, Kikuchi A (2006) Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66:10439-10448 (Pubitemid 44799765)
36. Sato A, Yamamoto H, Sakane H, Koyama H, Kikuchi A (2010) Wnt5a regulates distinct signalling pathways by binding to Frizzled2. EMBO J 29:41-54
37. Keeble TR, Halford MM, Seaman C, Kee N, Macheda M, Anderson RB, Stacker SA, Cooper HM (2006) The Wnt receptor Ryk is required for Wnt5a-mediated axon guidance on the contralateral side of the corpus callosum. J Neurosci 26:5840-5848 (Pubitemid 44315278)
38. Frojmark AS, Schuster J, Sobol M, Entesarian M, Kilander MBC, Gabrikova D, Nawaz S, Baig SM, Schulte G, Klar J, Dahl N (2011) Mutations in Frizzled 6 cause isolated autosomal-recessive nail dysplasia. Am J Hum Genet 88:852-860
39. Moskowitz SI, Jin T, Prayson RA (2006) Role of MIB1 in predicting survival in patients with glioblastomas. J Neurooncol 76:193-200 (Pubitemid 43125748)
40. Ho DM, Hsu CY, Ting LT, Chiang H (2003) MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma. Am J Clin Pathol 119:715-722 (Pubitemid 37046393)
41. Masckauchan TN, Agalliu D, Vorontchikhina M, Ahn A, Parmalee NL, Li CM, Khoo A, Tycko B, Brown AM, Kitajewski J (2006) Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell 17:5163-5172 (Pubitemid 44907359)